Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Polydex Pharmaceuticals Ltd/bahamas
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Polydex Pharmaceuticals Ltd/bahamas since year 2005.
Table 2 shows the detailed insider transactions of Polydex Pharmaceuticals Ltd/bahamas since 2005.
The reporting company's ticker symbol is POLXF. The reporting company's CIK number is 317158.
The total value of stock buying since 2005 is $67,280.
The total value of stock sales since 2005 is $23,432.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2008-08-25||Usher George G (President and CEO)||Buy||27,500||.60||16,500|
|2008-02-04||Usher George G (President and CEO)||Buy||17,943||.84||15,072|
|2008-01-14||Usher George G (President and CEO)||Buy||3,000||.88||2,640|
|2008-01-10||Usher George G (President and CEO)||Buy||11,000||.88||9,636|
|2007-07-26||Usher George G (President and CEO)||Buy||13,703||1.71||23,432|
|2007-07-26||Estate Of Thomas C Usher (10% Owner)||Sale||13,703||1.71||23,432|
Insider trading activities including stock purchases, stock sales, and option exercises of POLXF listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Polydex Pharmaceuticals Ltd/bahamas (symbol POLXF, CIK number 317158) see the Securities and Exchange Commission (SEC) website.